HLN Haleon Group Gross Profit Margin

HLN (Haleon Group) - company brandmark

Haleon plc is battling severe pricing pressure and the expansion of low-cost pharmacy brands. Gross margin dynamics clearly demonstrate the impact of these factors, with the indicator standing at 65.50. Efficiency is supported by the robotization of packaging with AI control. The company is currently focusing on autonomous warehouses and predictive logistics, having reached the technological limit in filling automation.

HLN - haleon.com Return on Gross Profit over the range 04/28/2023 - 11/20/2026

Analytical breakdowns and data insights for company Haleon plc (HLN)

- stock value and consensus price forecast:
Fundamental valuation:HLN, Haleon
Product sample of Haleon Corp

Investors expect high stability from Haleon plc, commensurate with the scale of this global consumer healthcare leader. By analyzing gross profit margins, we assess the portion of revenue remaining after covering direct production costs. This indicator reflects cost management efficiency and the brand's pricing power. The company's strong position in the pharmacy market allows it to maintain high profitability, confirming the fundamental resilience of the business.

Direct competitors

Gross Return on Sales KVUE|Gross Profitability veronapharma.com|Gross Return on Sales MENS (Jyong Biotech Corp)|Gross Profitability Ligand (LGND)|Gross Margin amneal.com (AMRX)|Gross Margin PRGO (perrigo.com)|Alvotech SA (ALVO) - Gross Profit Margin|Liquidia Inc. - Gross Margin|Gross Sales Margin Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Gross Profitability|Gross Return on Sales MNKD|Gross Profitability Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Return on Sales by Gross Profit|Gross Margin SPRY|TBPH - Gross Profit Margin|Aquestive Pharma - Return on Gross Profit|Gross Margin scpharmaceuticals.com SCPH|Tectonic - Gross Margin|TNXP - Gross Margin|SXTC: Gross Margin|Eupraxia Pharma - Gross Profit Rate|BHST (bioharvest.com) - Gross Margin|Gross Return on Sales EXOZ (invizyne.com)|Gross Margin ORMP|Return on Sales by Gross Profit Entera Bio|Gross Margin HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Gross Profitability|Cumberland Corp - Gross Margin|QNTM - Gross Margin|FibroGen, Inc. (FGEN) - Gross Profitability|TELO: Gross Profit Ratio|RANI (Rani Therapeutics Inc) - Gross Margin|Gross Profit Margin synergychc.com SNYR|Gross Profitability Rallybio Corp. (RLYB)|LEXX - Gross Profit Margin|Gross Margin PULM (pulmatrix.com)|Gross Profit Ratio PTHL (Pheton)|APM - Gross Profitability|Return on Sales by Gross Profit Lyra Therapeutics Inc LYRA|impactbiomedinc.com (IBO) - Gross Profitability|TNF Pharma (TNFA) - Gross Margin|YCBD (cbdmd.com) - Gross Margin|Return on Gross Profit PainReform (PRFX)|Gross Profitability Altamira Therapeutics (CYTO)|Return on Sales by Gross Profit Lipella Pharma|Optinose - Return on Gross Profit|Return on Sales by Gross Profit pieris.com (PIRS)|PROC - Gross Profitability|Gross Profitability Margin PTPI|QLI: Gross Margin|Gross Profit Margin ACELYRIN Inc. (SLRN)|TFFP (TFF Pharmaceuticals, Inc) - Gross Margin